logo
Select company
Select metric
$ -18.98MConsolidated Income
VS
Market
29
Sector
56
Industry
47
History
65
$ 1.03Close
$ 0.74 - $ 1.88 52-Week Range
Ticker Information

Ticker

XWEL

Company Name

XWELL INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

XWELL INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XWEL - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -18.98M
3/31/2025$ -18.72M
12/31/2024$ -16.49M
9/30/2024$ -15.4M
6/30/2024$ -20.67M
3/31/2024$ -24.56M
12/31/2023$ -28.03M
9/30/2023$ -35.75M
6/30/2023$ -33.45M
3/31/2023$ -35.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XWELL INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -82.8M.
  • Over the past 5 years, XWELL INC's average Cons. Inc. has been $ -29.83M.
  • The median Cons. Inc. for XWELL INC during this period was $ -22.61M
  • XWELL INC reached its highest Cons. Inc. over the past 5 years at $ 2.89M.
  • The lowest Cons. Inc. recorded by XWELL INC in the same timeframe $ -92.23M

XWELL INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
SSKN : STRATA SKIN SCIENCES INC $ -11.54MBIAF : BIOAFFINITY TECHNOLOGIES INC $ -11.69MSBFM : SUNSHINE BIOPHARMA INC $ -6.31MISPC : ISPECIMEN INC $ -10.19MSRXH : SRX HEALTH SOLUTIONS INC $ -16.09MYCBD : CBDMD INC $ -1.51MBNBX : APPLIED DNA SCIENCES INC $ -13.3MLFWD : LIFEWARD LTD $ -29.76MMSPR : MSP RECOVERY INC $ -1.65BEVOK : EVOKE PHARMA INC $ -5.38M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

XWEL - Consolidated Income, Last 5 years

$ -92.23M

Minimum

Dec 31, 2020

$ 2.89M

Maximum

Dec 31, 2021

$ -29.83M

Average

$ -22.61M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 11.93M with a standard deviation of $ 116.36M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 376.91M
average$ 11.93M
median$ -2.09M
std$ 116.36M